Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: Germany Clear all

255 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20015
20025
20034
20047
200510
200616
200712
200814
200915
201014
201113
201211
201313
201414
201519
201619
201713
20189
20199
20209
20215
20225
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed255

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company30
Hoffmann-La Roche22
Novartis Pharmaceuticals19
Boehringer Ingelheim14
AstraZeneca12
Bristol-Myers Squibb12
Pfizer10
Bayer8
GlaxoSmithKline8
Merck KGaA, Darmstadt, Germany7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung255
Lung Neoplasms50
Neoplasms16
Neoplasm Metastasis14
Melanoma10
Breast Neoplasms9
Colorectal Neoplasms8
Carcinoma7
Adenocarcinoma5
Adenocarcinoma of Lung5

Trials

Showing 1 to 25 of 255. Each trial links to its page on Pharma Observatory.

155 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.